Molecular Imaging for Radiation Therapy

In anatomic-based planning, differentiating non-viable and viable parts of a tumor can be difficult. This could result in disproportionate target volumes and radiation delivery to healthy tissue. MI distinguishes between high metabolically active tumor regions and areas of necrosis for early, precise, target volume definition allowing the physician improved dose escalation and treatment monitoring.